Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database

Response to sunitinib malate (SM) in alveolar soft part sarcoma (ASPS)

(2017) S. Stacchiotti et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy

(2012) Silvia Stacchiotti et al.   CANCER

Patient Selection for Oncology Phase I Trials: A Multi-Institutional Study of Prognostic Factors

(2012) David Olmos et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical benefit of early phase clinical trial participation for advanced sarcoma patients

(2010) Robin L. Jones et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials

(2010) Piotr Rutkowski et al.   JOURNAL OF CLINICAL ONCOLOGY

Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor

(2010) James E. Butrynski et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials

(2009) Hendrik-Tobias Arkenau et al.   JOURNAL OF CLINICAL ONCOLOGY